Oral anticoagulants for atrial fibrillation and acute coronary syndrome with or without stenting

J Cardiovasc Med (Hagerstown). 2018 Feb:19 Suppl 1:e40-e45. doi: 10.2459/JCM.0000000000000597.

Authors

Francesca Muscente¹, Gerda Tautermann², Raffaele De Caterina¹

Affiliations

¹ Institute of Cardiology and Cardiology Department, D'Annunzio University, Chieti-Pescara, Italy.
² Department of Medicine and Cardiology, Academic Teaching Hospital and VIVIT Institute, Feldkirch, Austria.

PMID: 29538143
DOI: 10.2459/JCM.0000000000000597

No abstract available

Publication types

Review

MeSH terms

Acute Coronary Syndrome / diagnosis
Acute Coronary Syndrome / mortality
Acute Coronary Syndrome / physiopathology
Acute Coronary Syndrome / surgery*
Administration, Oral
Anticoagulants / administration & dosage*
Anticoagulants / adverse effects
Atrial Fibrillation / diagnosis
Atrial Fibrillation / drug therapy*
Atrial Fibrillation / mortality
Atrial Fibrillation / physiopathology
Evidence-Based Medicine
Hemorrhage / chemically induced
Humans
Percutaneous Coronary Intervention / adverse effects
Percutaneous Coronary Intervention / instrumentation*
Percutaneous Coronary Intervention / mortality
Platelet Aggregation Inhibitors / administration & dosage
Risk Factors
Stents*
Time Factors
Treatment Outcome

Substances

Anticoagulants
Platelet Aggregation Inhibitors